
Developer of T-cell immunotherapy products. The company focuses on the development and commercialisation of engineered T-cell immunotherapy products for the treatment of life-threatening cancers.

Tell Autolus you're interested in working at the company, while keeping your personal identity anonymous. Comparably will give Autolus the opportunity to hire you. When there's a job opening that's a fit we'll make the match happen.
In 2019, Autolus applied for 1 H1B visas. Of the work permits applied for, 100% were approved.
Autolus has a total of 29 employees
H1B Applications Outcome
This data was calculated using publicly sourced data from OFLC Performance Data
Send them an invite to rate the company culture.